Products for Research Use Only
RegisterLogin

TLT8

CAT: 0804-HY-172822Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-172822Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
TLT8 is a ByeTAC protein degrader targeting BTK. TLT8 non-covalently binds to Rpn-13 and BTK, thereby inducing BTK degradation. TLT8 can be used in chronic lymphocytic leukemia research. (Rpn-13 ligand: HY-159808; BTK ligand: HY-Z3101; linker: HY-172823).
UNSPSC
12352211
Target
Btk; ByeTAC
Related Pathways
PROTAC; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
NC1=C2C(C3=CC=C(C=C3)OC4=CC=CC=C4)=NN(C2=NC=N1)[C@H]5CCCN(C5)C(CCC(NCCOCCOCCOCCOCCOCCOCCOCCOCCNC(CC6SC7=NN=C(N7N=C6C8=CC=C(C=C8)Cl)CC9=CC=C(C=C9)Br)=O)=O)=O
Molecular Formula
C63H76BrClN12O12S
Molecular Weight
1340.77
References & Citations
[1]Loy CA, et al. ByeTAC: Bypassing E-Ligase-Targeting Chimeras for Direct Proteasome Degradation. J Med Chem. 2025 Apr 19.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P84635-01TLT2 Antibody (YA4332, Mouse)

Alternative Products

CatalogName
T206849-01TLT8

Popular Products